Clinical Trial Update: Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF) [Phase 3]

View source ↗

Summary

Phase 3 trial update for ataluren in nonsense mutation cystic fibrosis has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• ataluren (ataluren)

Snippet

Sponsor: PTC Therapeutics | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2020-05-14